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This is the first report describing a severe form of cold ag-
glutinin-induced acrocyanosis with cutaneous necrosis af-
ter Mycoplasma infection in a 9-year-old patient without 
any other severe symptoms and laboratory alterations. 
We also present the results of two non-invasive methods 
used to determine the viability of tissues, degree of tissue 
perfusion impairment, and the responsiveness of the mi-
crovasculature. Laser Doppler flowmetry and laser speckle 
contrast imaging, both suitable to measure tissue blood 
perfusion non-invasively, have been used in the diagno-
sis and follow-up of various peripheral vascular diseases. 
In our patient, we demonstrated remarkably reduced mi-
crocirculation before the treatment and a significant per-
fusion increase in the acral regions after pentoxifylline 
therapy. The investigational techniques were useful tools 
to assess and quantify the severity of peripheral perfusion 
disturbances and to monitor the efficacy of the treatment 
in our patient.
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Acrocyanosis is a vascular disease usually characterized by 
persistent, non-paroxysmal, bluish-red symmetrical dis-
coloration of the hands and feet. It may also affect the ear 
lobes and the tip of the nose. The disease usually manifests 
before the age of 25. Acrocyanosis can occur in the pri-
mary form without detectable previous disease or in the 
secondary form resulting from specific disorders, such as 
cold agglutinin syndrome (CAS) (1-3).
Together with paroxysmal cold hemoglobinuria (PCH), 
the CAS is classified into the group of cold autoimmune 
hemolytic anemias, representing a subgroup of autoim-
mune hemolytic anemias. The diagnosis of these clinically 
distinctive disorders is based on their characteristic sero-
logic reactions. CAS is etiologically further divided into id-
iopathic and secondary forms caused by underlying non-
malignant or malignant diseases (3).
In contrast to PCH, CAS is generally caused by IgM autoan-
tibodies that exhibit their maximum reactivity at 4°C. Cold 
agglutinins (CA) circulate in nearly everyone, but in low titer 
(3,4), whereas clinically significant agglutinins occur at ti-
ters of 1:1000 with thermal activity range extended toward 
warmer temperatures. When blood temperature drops be-
low the thermal maximum of the antibody, IgM binds to 
erythrocytes and causes agglutination and complement 
activation responsible for hemolysis. The clumped eryth-
rocytes may occlude peripheral microvasculature, which 
may lead to acrocyanosis and, in severe cases, ischemic 
gangrenes.
The characteristic clinical manifestations of CAS consist 
of hemoglobinuria, acrocyanosis, Raynaud’s phenome-
non, cutaneous necrosis, and occasionally gangrene. The 
symptoms appear or worsen typically at cold temperature 
(2,3,5), but the extent of the hypoperfusion is not routinely 
measured in the clinical practice.
To the best of our knowledge, this is the first case report 
of severe acrocyanosis precipitated by cold agglutinin sec-
ondary to infection with Mycoplasma pneumoniae in a pe-
diatric patient. A further novelty of the case is the use of 
two non-invasive techniques, not used in routine practice, 
to determine the severity of microcirculatory impairment 
and evaluate the effectiveness of therapy.
CASE REPORT
A 9-year-old Caucasian girl, born at 39 weeks of gestation 
after an uneventful pregnancy, had been taking inhaled 
steroid (fluticasone proprionate) medication for asthma for 
2 years, but otherwise had an unremarkable medical his-
tory. She had undergone all routine immunizations at the 
appropriate ages.
The patient had become subfebrile and developed un-
productive cough two weeks before admission to hospi-
tal. She was treated with amoxicillin-clavulanate antibiot-
ic and fluticasone proprionate and salbutamol inhalation. 
One week later, painful, bluish discoloration of the fingers 
occurred, which was worsening in cold temperature. She 
was referred to our emergency unit.
On physical examination, the patient’s fingers and toes 
were cold, blue, and tender, with a small cutaneous ne-
crosis of the digital phalanx of the fourth finger (Figure 1). 
Sclerodactyly was not observed. Radial and axillary pulses 
on both sides were equal and regular, and blood pressure 
and heart rate were in the normal range. The elevated arm 
test was not indicative for thoracic outlet syndrome. Crepi-
tation was observed above the middle lobe of the right 
lung. No further abnormalities were seen on physical and 
neurological examination.
Routine laboratory tests including hematocrit (Htc), he-
moglobin (Hgb), white blood cell count (WBC), platelets, 
differential blood smear, C- reactive protein (CRP), lactate 
dehydrogenase (LDH), transaminases, thyroid stimulating 
hormone (TSH), coagulation parameters, and serum cre-
atinine. All laboratory findings were in reference ranges, 
while erythrocyte sedimentation rate (ESR) was slightly in-
creased. Urinalysis was not indicative for hemolysis. Immu-
FiguRE 1. Severe acrocyanosis with cutaneous necrosis in 
the 9-year-old female patient (photo taken at the time of first 
admission).
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noglobulin and complement C3 and C4 levels were also 
normal and the screening test excluded the presence of 
cryoglobulins. Direct antiglobulin test (Coombs test) de-
tected the presence of both IgM and C3d. IgM exhibited 
a peak auto-agglutination at 4°C; its reactivity gradually 
vanished above room temperature and became inactive 
at 37°C (Table 1).
Immunoserological investigations revealed increased an-
ti-nucleosoma antibody (76.9 UI/mL, normal <20 UI/mL), 
while other autoantibodies (anti-nuclear, anti-dsDNA, an-
ti-centromere, anti-C1Q, extractable nuclear antibody, an-
ti-saccharomyces cerevisieae antibodies, anti-neutrophil 
cytoplasmic antibodies, anticardiolipin and anti-beta 2 gly-
coprotein, and antiprothrombin) were in the normal range. 
Infectious serology results for Epstein-Barr virus, cytomega-
lovirus, Varicella zoster virus, human immunodeficiency vi-
rus (HIV)-1,-2, Parvovirus B19, Hepatitis -A, -B, -C, -E virus, 
Chlamydia pneumoniae excluded recent infections. The 
antistreptolysin-O titer was normal. The venereal diseas-
es research laboratory test VDRL was non-reactive. Myco-
plasma IgM and IgA antibodies were markedly increased, 
whereas IgG was slightly increased, ie, these findings indi-
cated recent Mycoplasma pneumoniae infection.
Chest x-ray revealed pneumonia in the right lobe. Ab-
dominal ultrasound findings were normal. Echocardiogra-
phy showed normal cardiac anatomy, and the patient had 
good peripheral pulses with normal flow on Doppler ex-
amination. Ophthalmological examination was not indica-
tive for vasculitis. Ramified capillaries were observed with 
capillary microscopy.
TABlE 1. Thermal activity of cold agglutinins at different time 
points
Cold agglutinins activity*
Date of examination 4°C 15°C 20°C 25°C
December 10, 2014 ++++ ++ + -
May 20, 2015 +++ ++ +/− -
January 10, 2016 +++ ++ - -
*The positive agglutination reaction is graded by a semiquantitative 
score from + to 4+.
TABlE 2. Numerical data characterizing the baseline blood 
flow and the heat-induced perfusion increase in our patient 
and a healthy child, calculated from the measurements with 
the Periflux 5000 system*
Mean perfusion (arbitrary units) latency to reach
at 32°C at 42°C maximum (minutes)
Patient  36.14 126.74 4:12
Healthy 455.70 811.65 0:51
*Data from the 44°C stimulation not shown as we did not measure any 
apparent increase during this period compared with the 42°C heating.
FiguRE 2. Measurement of blood flow with the Periflux 5000 system at basal temperature (i. at 32°C, 5 minutes), and after heating 
to 42°C (ii.), then to 44°C (iii.) in our patient (left panel). The blue trace shows the perfusion measured in arbitrary units by the equip-
ment (Pu: perfusion unit), the red trace shows the temperature of the probe, and the red arrows on the top indicate the time points 
of heating. For comparison, the right panel shows the heat-induced perfusion increase of a healthy child. Note that the Pu scale is 
set differently due to the severely reduced perfusion of the patient.
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On the basis of clinical examination and laboratory test re-
sults, we reasonably suspected that the girl had acrocya-
nosis precipitated by cold agglutinin secondary to Myco-
plasma pneumoniae infection. Autoimmune disorders and 
drug-induced acrocyanosis were ruled out on the basis of 
medical history and laboratory test results.
The patient was treated for 2 weeks with oral clarithromy-
cin and intravenous pentoxyphyline infusions (200 mg/
dose) three times a week in the beginning. No adverse 
events occurred during pentoxyphyline treatment. After 
the first 3 months of therapy, the frequency of infusions 
was set to every 2-3 weeks according to the improving 
clinical signs and continued for 12 months every three 
weeks. No plasma exchange therapy was needed. The pa-
tient was advised to avoid cold temperatures and keep her 
peripheries warm, eg, by wearing gloves. There were no 
problems with adherence to medical advice.
Since the symptoms persisted for over two months after 
the first admission, we decided to use two non-invasive 
methods to determine the viability of tissues, the degree 
of tissue perfusion impairment, and the responsiveness of 
the microvasculature.
Periflux 5000 system (Perimed AB, Stockholm, Sweden) 
uses the Laser Doppler Flowmetry (LDF) technology for 
perfusion measurement. A thermostatic Laser Doppler 
probe was placed on the distal phalanx of the second fin-
ger of the right hand to measure the effect of local heating 
on skin microcirculation (42°C for 15 minutes then to 44°C 
for 5 minutes). Severely reduced basal blood flow was de-
tected on the affected fingers with delayed vasodilatation 
after local heating (Table 2, Figure 2).
The Laser Speckle Contrast Analysis (LASCA) technology 
used by the PeriCam PSI equipment (Perimed AB, Stock-
holm, Sweden) allows real-time cutaneous perfusion imag-
ing of larger body parts in several regions of interest (ROIs) 
simultaneously. This measurement also showed reduced 
TABlE 3. Mean perfusion values of entire regions of interest 
(ROi) of equal size representing each fingertip before and 1 
hour after intravenous pentoxyphyline treatment (200 mg) 
with the PeriCam PSi System






1st finger 122.80 212.39  73.0
2nd finger  67.49 135.78 101.2
3rd finger  62.73 132.73 111.6
4th finger 104.19 149.49  43.5
5th finger  69.96 139.38  99.2
Dorsum of the 
hand
 49.68  56.30  13.3
FiguRE 3. Representative images of laser Speckle Contrast Analysis (lASCA) measurements. A. lASCA measurements performed 
on the left hand before pentoxyphyline infusion (200 mg iV) with the PeriCam PSi System. B. lASCA measurements performed on 
the left hand 1 hour after intravenous pentoxyphyline infusion (200 mg) with the PeriCam PSi System. The perfusion is measured in 
arbitrary perfusion units (Pu) by the equipment and imaged on a color scale. Higher numbers and yellow-red color shades represent 
higher perfusion values. Equal-sized regions of interests (ROis) were selected on each finger and on the dorsal side of the hand. The 
ROi outlines were enhanced and enlarged number legends for ROis were added during image post-processing to allow visibility for 
publication.
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perfusion in the acral regions and a significant perfusion 
increase in response to an acute 2-h-long pentoxyphyline 
infusion (200 mg) 1 hour after finishing the treatment (Ta-
ble 3, Figure 3).
At the follow-up visit after 6 months, the patient had mild 
symptoms, and the laboratory parameters returned to ref-
erence ranges. So far, she has not received any treatment 
for one and a half years or had any symptoms of vascular 
disease (Table 4).
DiSCuSSiON
This is the first report describing a pediatric case of cold 
agglutinin-induced acrocyanosis after Mycoplasma infec-
tion without any other severe symptoms and laboratory 
alterations. The diagnosis of severe forms of acrocyanosis 
is generally challenging and it can take weeks to identify 
the background of the diagnosis. Therefore, we used LDF 
and LASCA techniques as non-invasive investigational 
tools to assess and quantify the severity of the perfusion 
disturbances and monitor the effectiveness of the treat-
ment. However, there was no long-term follow-up of the 
microcirculatory changes and vascular responsiveness af-
ter complete remission of the symptoms.
Severe acrocyanosis with cutaneous necrosis rarely occurs 
in children and it is mostly reported in association with sys-
temic autoimmune disorders, such as systemic lupus ery-
thematosus, systemic sclerosis, infection-induced cold ag-
glutinin disease, and drug-induced acrocyanosis (1,2,6). We 
excluded the presence of autoimmune diseases on the ba-
sis of the laboratory tests. Psychomotor stimulants used 
for attention-deficit/hyperactivity disorder could also 
provoke acrocyanosis, but this patient was not treated 
with this type of drugs. The most likely cause of se-
vere acrocyanosis was infection-induced cold agglutinin 
disease, which was supported by the respiratory infection 
two weeks earlier, the detectable cold-agglutinin at room-
temperature, and the positive serological assay for M. pneu-
moniae infection.
Cold agglutinin disease accounts for about 10%-20% of all 
autoimmune hemolytic anemias. While idiopathic and sec-
ondary malignant disorders affect elderly people, the sec-
ondary post-infectious CAS is seen in adolescents, young 
adults and sometimes in children, especially in those with 
chickenpox (3,7-10). Despite the high incidence of infec-
tions that induce cold agglutinins, the titer and thermal 
amplitude of the antibodies are only rarely present in the 
pathologic range; therefore, these infections are seldom 
complicated with CAS. Symptomatic CAS mostly co-oc-
curs with acute hemolysis in M. pneumoniae infections 
when the patient is recovering from the pneumonia, in 
parallel with peak titers of cold agglutinins. The antibody 
occurs 2 weeks after the onset of the primary infection, 
reaches peak titer quickly, and may persist for 3-4 months. 
Hemolysis is self-limited, lasting for 1 to 3 weeks (4,7,11,12). 
However, in our patient, CAS manifested without hemo-
lysis. Acrocyanosis of the fingers, toes, nose, and ears is 
caused by erythrocyte sludging in the microvasculature, 
but ulceration and necrosis are uncommon. Other find-
ings are variable and depend on the underlying disease 
(3,4,13,14). Less commonly, other viral or bacterial patho-
gens, such as cytomegalovirus, influenza virus, varicella 
virus, Legionella, Citrobacter, and some strains of Listeria 
monocytogenes can also induce oligoclonal cold aggluti-
nin production (8-11,15).
The disease variability depends on several pathophysio-
logic factors (16). IgM weakly binds to the polysaccharide 
antigen at ambient temperature, but the higher the ther-
TABlE 4. Timeline of patient’s signs and symptoms and treatment
Date Signs and symptoms
November 10, 2014 Subfebrility, cough - amoxicillin-clavulanate antibiotic and fluticasone propionate, salbutamol inhalation 
treatments
November 17, 2014 Painful, bluish discoloration of fingers
November 24, 2014
admission to hospital
Severe acrocyanosis with cutaneous necrosis of the digital phalanx of the fourth finger, pneumonia l.d. – 
clarithromycin and pentoxyphyline treatment
second week of 
hospitalization
Systemic autoimmune diseases were ruled out, serological test suggested recent Mycoplasma pneumoniae 
infection
January 2015 LDF and LASCA methods
May 2015 The patient had mild symptoms, the laboratory parameters returned to reference ranges
February 2016 Last pentoxyphyline infusion
March 2016 No symptoms of vascular disease
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mal amplitude of the antibodies, the greater the possibil-
ity of reaching the critical temperature at the periphery. 
Although the thermal range is the most important factor, 
the clinical manifestation of cold agglutinins in these infec-
tions is invariably associated with elevated titers ranging 
between 512 and 32 000 (3). Another factor is the capabil-
ity of the IgM to fix complement. Since phagocytic cells 
do not have IgM receptors, red blood cell destruction is 
complement-mediated. Some cold agglutinins do not fix 
complement and patients with such antibodies may have 
severe agglutination symptoms (acrocyanosis) without 
hemolysis (17-20).
We demonstrated the severely impaired perfusion of the 
patient’s fingers with two non-invasive techniques, the 
LDF and LASCA. Both microcirculation measurement tech-
niques rely on the analysis of reflected light from moving 
red blood cells and the calculated perfusion unit is propor-
tional to the number and velocity of circulating red blood 
cells in the examined tissue. While LDF is often used for the 
diagnosis and follow-up of peripheral vascular diseases, 
such as diabetic microangiopathy, atherosclerosis, wound 
healing after burns, or reconstructive surgery in adults (21-
24), LASCA is a novel technique for the study of microcir-
culation without any routine applications in the clinics (25-
27). Neither of the methods has been used in the pediatric 
practice. In the present case, we demonstrated the useful-
ness of both methods. Impaired perfusion was reliably de-
tected by both LDF and LASCA. In addition, it was revealed 
that the heat-induced hyperemic response was dimin-
ished and improved microcirculation of the acral regions 
after pentoxyphyline infusion was sensitively measured by 
the LASCA imaging method.
The primary take-away lesson in this case is that if a child 
presents with atypical Raynaud’s-like symptoms, it should 
alert the clinician to suspect cold agglutinin disease. Cold 
agglutinin-induced acrocyanosis after Mycoplasma infec-
tion can develop in children without hemolysis.
Acknowledgment The authors wish to thank the nurses who participated 
in the assessment and treatment of the patient. This work is dedicated to 
the 650th anniversary of the University of Pécs and was supported by “Stay 
Alive” GINOP-2.3.2.-15-2016-00048 grant.
Funding None disclosed.
Ethical approval was not required. The patient’s parents gave a written in-
formed consent to write this case report.
Declaration of authorship BM and ZN participated in the diagnosis and 
treatment of the patient, AN, KB, and ZH participated in the perfusion mea-
surements and in the analysis of data. BM, ZN, KB, ZH, and TD drafted the 
manuscript. ZH and KB supervised the work. All authors read and approved 
the final version of the manuscript.
Competing interests All authors have completed the Unified Competing 
Interest form at www.icmje.org/coi_disclosure.pdf (available on request 
from the corresponding author) and declare: no support from any organi-
zation for the submitted work; no financial relationships with any organiza-
tions that might have an interest in the submitted work in the previous 3 
years; no other relationships or activities that could appear to have influ-
enced the submitted work.
References
1 Heidrich H. Functional vascular diseases: Raynaud’s syndrome, 
acrocyanosis and erythromelalgia. Vasa. 2010;39:33-41. 
Medline:20186674 doi:10.1024/0301-1526/a000003
2 läuchli S, Widmer l, lautenschlager S. Cold agglutinin disease-
the importance of cutaneous signs. Dermatology. 2001;202:356-8. 
Medline:11455160 doi:10.1159/000051682
3 McNicholl FP. Clinical syndromes associated with cold agglutinins. 
Transfus Sci. 2000;22:125-33. Medline:10771401 doi:10.1016/
S0955-3886(00)00033-3
4 Berentsen S, Tjřnnfjord gE. Diagnosis and treatment of cold 
agglutinin mediated autoimmune hemolytic anemia. Blood Rev. 
2012;26:107-15. Medline:22330255 doi:10.1016/j.blre.2012.01.002
5 Sinha A, Richardson g, Patel RT. Cold agglutinin related 
acrocyanosis and paroxysmal haemolysis. Eur J Vasc Endovasc 
Surg. 2005;30:563-5. Medline:16023873 doi:10.1016/j.
ejvs.2005.05.031
6 Coulombe J, Powell J, Hatami A, McCuaig C, Renet S, Marcoux 
D. Diseases of abnormal sensitivity to cold in children on 
psychostimulant drugs. J Cutan Med Surg. 2015;19:121-4. 
Medline:25775630 doi:10.2310/7750.2014.14052
7 Petz lD. Cold antibody autoimmune hemolytic anemias. 
Blood Rev. 2008;22:1-15. Medline:17904258 doi:10.1016/j.
blre.2007.08.002
8 Swiecicki Pl, Hegerova lT, gertz MA. Cold agglutinin disease. 
Blood. 2013;122:1114-21. Medline:23757733 doi:10.1182/blood-
2013-02-474437
9 Karunarathne S, Weerasinghe S, govindapala D, Fernando H, 
Jayaratne B. Cold autoimmune haemolytic anaemia secondary 
to Epstein Barr virus infection presenting with peripheral 
gangrene; case report. Thromb J. 2012;10:4. Medline:22513360 
doi:10.1186/1477-9560-10-4
10 Harel l, Straussberg R, Rudich H, Cohen AH, Amir J. Raynaud’s 
phenomenon as a manifestation of parvovirus B19 infection: case 
reports and review of parvovirus B19 rheumatic and vasculitic 
syndromes. Clin infect Dis. 2000;30:500-3. Medline:10722434 
doi:10.1086/313712
11 Hamblin T. Management of cold agglutination syndrome. Transfus 
Sci. 2000;22:121-4. Medline:10771400 doi:10.1016/S0955-
3886(00)00032-1
12 Packman CH. The Clinical Pictures of Autoimmune 
Hemolytic Anemia. Transfus Med Hemother. 2015;42:317-24. 
Medline:26696800 doi:10.1159/000440656
13 Nydegger uE, Kazatchkine MD, Miescher PA. immunopathologic 
CASE REPORT430 Croat Med J. 2017;58:424-30
www.cmj.hr
and clinical features of hemolytic anemia due to cold agglutinins. 
Semin Hematol. 1991;28:66-77. Medline:1708169
14 Jacobson lB, longstreth gF, Edgington TS. Clinical and 
immunologic features of transient cold agglutinin-hemolytic 
anemia. Am J Med. 1973;54:514-21. Medline:4633107 
doi:10.1016/0002-9343(73)90047-8
15 luzuriaga K, Sullivan Jl. infectious mononucleosis. N Engl J 
Med. 2010;362:1993-2000. Medline:20505178 doi:10.1056/
NEJMcp1001116
16 Rosse WF, Adams JP. The variability of hemolysis in the cold 
agglutinin syndrome. Blood. 1980;56:409-16. Medline:7407408
17 Zilow g, Kirschfink M, Roelcke D. Red cell destruction in cold 
agglutinin disease. infusionsther Transfusionsmed. 1994;21:410-5. 
Medline:7873920
18 Kirschfink M, Knoblauch K, Roelcke D. Activation of complement 
by cold agglutinins. infusionsther Transfusionsmed. 1994;21:405-9. 
Medline:7873919
19 Jaffe CJ, Atkinson JP, Frank MM. The role of complement in the 
clearance of cold agglutinin-sensitized erythrocytes in man. J Clin 
invest. 1976;58:942-9. Medline:965497 doi:10.1172/JCi108547
20 Atkinson JP, Frank MM. Studies on the in vivo effects of antibody. 
interaction of igM antibody and complement in the immune 
clearance and destruction of erythrocytes in man. J Clin invest. 
1974;54:339-48. Medline:4847248 doi:10.1172/JCi107769
21 Roustit M, Blaise S, Millet C, Cracowski Jl. Reproducibility and 
methodological issues of skin post-occlusive and thermal 
hyperemia assessed by single-point laser Doppler flowmetry. 
Microvasc Res. 2010;79:102-8. Medline:20064535 doi:10.1016/j.
mvr.2010.01.001
22 Jaskille AD, Ramella-Roman JC, Shupp JW, Jordan MH, Jeng JC. 
Critical review of burn depth assessment techniques: part ii. 
Review of laser doppler technology. J Burn Care Res. 2010;31:151-7. 
Medline:20061851 doi:10.1097/BCR.0b013e3181c7ed60
23 Skrha J, Prázný M, Haas T, Kvasnicka J, Kalvodová B. Comparison 
of laser-Doppler flowmetry with biochemical indicators of 
endothelial dysfunction related to early microangiopathy in Type 
1 diabetic patients. J Diabetes Complications. 2001;15:234-40. 
Medline:11522496 doi:10.1016/S1056-8727(01)00152-0
24 Hu C-l, lin Z-S, Chen Y-Y, lin Y-H, lai M-F, li M-l. Application of 
the laser Doppler flowmeter for measurement of blood pressure 
and functional parameters of microcirculation. Biomed Mater Eng. 
2012;22:351-9. Medline:23114464
25 Ruaro B, Sulli A, Pizzorni C, Paolino S, Smith V, Alessandri E, et al. 
Correlations between blood perfusion and dermal thickness in 
different skin areas of systemic sclerosis patients. Microvasc Res. 
2018;115:28-33. Medline:28834709 doi:10.1016/j.mvr.2017.08.004
26 Krezdorn N, limbourg A, Paprottka FJ. Könneker, ipaktchi R, 
Vogt PM. Assessing burn depth in tattooed burn lesions with 
lASCA imaging. Ann Burns Fire Disasters. 2016;29:223-7. 
Medline:28149254
27 Sandker SC. Hondebrink E, grandjean Jg, Steenbergen W. laser 
speckle contrast analysis for quantifying the Allen test: a feasibility 
study. lasers Surg Med. 2014;46:186-92. Medline:24302298 
doi:10.1002/lsm.22213
